Skip to content

Chemed Corp (CHE) stock: revenue, earnings & dividend

Chemed Corp (CHE, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener CHE · NYSE Gesundheitswesen US-OH

Key figures

Fiscal year
2025
Revenue
2.53 bn $
Revenue growth
4.1 %
Revenue growth 5y (p.a.)
4 %
Net income
265,238 $
Net margin
0 %
Operating margin
13.4 %
Earnings per share (diluted)
18.34 $
Dividend per share
2.20 $
Payout ratio
12 %
Consecutive dividend years
17 years
Consecutive dividend raises
16 years
Dividend growth 5y (p.a.)
10.8 %
Total assets
1.54 bn $
Equity
979 m $
Equity ratio
63.7 %
Return on equity
0 %
Cash
74.5 m $
Operating cash flow
388 m $
Free cash flow
325 m $
Shares outstanding
13,014,915

History

Revenue by fiscal year

2016 1.58 bn $
2017 1.67 bn $
2018 1.78 bn $
2019 1.94 bn $
2020 2.08 bn $
2021 2.14 bn $
2022 2.13 bn $
2023 2.26 bn $
2024 2.43 bn $
2025 2.53 bn $

Net income by fiscal year

2016 109 m $
2017 98.2 m $
2018 206 m $
2019 220 m $
2020 319 m $
2021 268,550 $
2022 249,624 $
2023 272,509 $
2024 301,999 $
2025 265,238 $

Dividend per share

2016 1.00 $
2017 1.08 $
2018 1.16 $
2019 1.24 $
2020 1.32 $
2021 1.40 $
2022 1.48 $
2023 1.56 $
2024 1.80 $
2025 2.20 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20252.53 bn $265,238 $18.34 $2.20 $388 m $
20242.43 bn $301,999 $19.89 $1.80 $417 m $
20232.26 bn $272,509 $17.93 $1.56 $330 m $
20222.13 bn $249,624 $16.53 $1.48 $310 m $
20212.14 bn $268,550 $16.85 $1.40 $309 m $
20202.08 bn $319 m $19.48 $1.32 $489 m $
20191.94 bn $220 m $13.31 $1.24 $301 m $
20181.78 bn $206 m $12.23 $1.16 $287 m $
20171.67 bn $98.2 m $5.86 $1.08 $162 m $
20161.58 bn $109 m $6.48 $1.00 $135 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)